Immuno Oncology Assays | An Emerging Market Growing at a CAGR of 12.7%
The
global immuno oncology assays market
to grow from USD 2.9 billion in 2018 to USD 5.9 billion by 2024, at a CAGR of 12.7%
during the forecast period. The rising
incidence of cancer and increasing adoption of targeted therapy are
the key factors driving the market. Companion diagnostics have been identified as an area of opportunity for
companies seeking to develop innovative products or capabilities...
Immuno Oncology Assays Market Emerging and Latest Trends 2019
The global immuno-oncology assays market to grow from USD 2.9 billion in 2018 to USD 5.9 billion by 2024, at a CAGR of 12.7% during the forecast period. The rising incidence of cancer and increasing adoption of targeted therapy are the key factors driving the market. Companion diagnostics have been identified as an area of opportunity for companies seeking to develop innovative products or capabilities...